PK 11195 blockade of benzodiazepine-induced inhibition of forskolin-stimulated adenylate cyclase activity in the striatum

British Journal of Pharmacology

Volumn 119, Issue 2, 1996, Pages 223-228

  Tenn, Catherine C ^a   Neu, John M ^a   Niles, Lennard P ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

2 iodomelatonin; Adenylate cyclase; Benzodiazepine; Cyclic AMP; Diazepam; G(i) protein; Melatonin; Pertussis toxin; PK 11195; Ro5 4864

Indexed keywords

2 IODOMELATONIN; 4' CHLORODIAZEPAM; ADENYLATE CYCLASE; BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; CYCLIC AMP; DIAZEPAM; FLUMAZENIL; FORSKOLIN; GUANOSINE TRIPHOSPHATE; INDOLEAMINE; MELATONIN; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PERTUSSIS TOXIN;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029839898     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15974.x     Document Type: Article

References (26)

1. ALBERTSON, T.E., PETERSON, S.L., STARK., L.G., LAKIN, M.L. & WINTERS, W.D. (1981). The anticonvulsant properties of melatonin on kindled seizures in rats. Neuropharmacology, 20, 61-66.
2. BRAESTRUP, C. & NIELSEN, M. (1983). Benzodiazepine receptors. In Handbook of Psychopharmacology. Vol 17, ed. Iversen, L.L., Iversen, S.D. & Snyder, S.H. pp. 285-384. New York: Plenum Press.
3. 3H]-diazepam binding. Proc. Natl. Acad. Sci. U.S.A., 74, 3805-3809.
4. CACCIA, S., CARLI, M., GARATTINI, S., POGGESI, E., RECH, R. & SAMANIN, R. (1980). Pharmacological activities of clobazam and diazepam in the rat: Relation to drug brain levels. Arch. Int. Pharmacodyn., 243, 275-283.
5. CHAMPNEY, T.H. & CHAMPNEY, J-A.C. (1992). Novel anticonvulsant action of chronic melatonin in gerbils. NeuroReport, 3, 1152-1154.
6. COLWELL, C.S. & LEVINE, M.S. (1995). Excitatory synaptic transmission in neostriatal neurons: regulation of cyclic AMP-dependent mechanisms. J. Neurosci., 15, 1704-1713.
7. i and catalytic proteins. Life Sci., 42, 469-475.
8. 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther., 238, 248-253.
9. GOLOMBEK, D.A., FERNANDEZ DUQUE, D., DE BRITO SANCHEZ, M.G., BURIN, L. & CARDINALI, D.P. (1992). Time dependent anticonvulsant activity of melatonin in hamsters. Eur. J. Pharmacol., 210, 253-258.
10. GUARDIOLA-LEMAITRE, B., LENEGRE, A. & PORSOLT, R.D. (1992). Combined effects of diazepam and melatonin in two tests for anxiolytic activity in the mouse. Pharmacol. Biochem. Behav., 41, 405-408.
11. A receptors by benzodiazepine receptor ligands. In Allosteric Modulation of Amino Acid Receptors: Therapeutic Implications, ed. Barnard, E.A. & Costa, E. pp. 47-69. New York: Raven Press.
12. 2 -adrenoceptor-mediated inhibition of adenylate cyclase activity in cerebral cortical membranes of rats. J. Neurochem., 45, 1504-1508.
13. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
14. 3H]Ro5-4864. Mol. Pharmacol., 22, 26-32.
15. NILES, L.P. & HASHEMI, F.S. (1990). Pharmacological inhibition of forskolin-stimulated adenylate cyclase activity in rat brain by melatonin, its analogs, and diazepam. Biochem. Pharmacol., 40, 2701-2705.
16. NILES, L.P., YE, M., PICKERING, D.S. & YING, S-W. (1991). Pertussis toxin blocks melatonin-induced inhibition of forskolin-stimulated adenylate cyclase activity in the chick brain. Biochem. Biophys. Res. Commun., 178, 786-792.
17. A receptors. FASEB J., 4, 1469-1480.
18. OLIANAS, M.C. & ONALI, P. (1987). Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum. J. Neurochem., 48, 1443-1447.
19. PAPANICOLAOU, J., SUMMERS, R.J., VAJDA, F.J.E. & LOUIS, W.J. (1982). Anticonvulsant effects of clonidine mediated through central α2-adrenoceptors. Eur. J. Pharmacol., 77, 163-166.
20. PAROLA, A.L., YAMAMURA, H.I. & LAIRD, H.E. (1993). Peripheraltype benzodiazepine receptors. Life Sci., 52, 1329-1342.
21. PIERREFICHE G., ZERBIB, R. & LABORIT, H. (1993). Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors. Res. Commun. Chem. Path. Pharmacol., 82, 131-142.
22. SALOMON, Y., LONDOS, C. & RODBELL, M. (1974). A highly sensitive adenylate cyclase assay. Anal. Biochem., 59, 541-548.
23. SCHEININ, H., VIRTANEN, R., MACDONALD, E., LAMMINTAUSTA. R. & SHEININ, M. (1989). Medetomidine-a novel-adrenoceptor agonist: a review of its pharmacodynamic effects. Prog. Neuropsychopharmacol. Biol. Psychiatry, 13, 635-651.
24. TALLMAN, J.F., PAL, S.M., SKOLNICK, P. & GALLAGER, D.W. (1980). Receptors for the age of anxiety: Pharmacology of benzodiazepines. Science, 207, 274-281.
25. TENN, C.C. & NILES, L.P. (1995). Central-type benzodiazepine receptors mediate the antidopaminergic effect of clonazepam and melatonin in 6-hydroxydopamine lesioned rats: involvement of a GABAergic mechanism. J. Pharmacol. Exp. Ther., 274, 84-89.
26. YING, S-W., NILES, L.P., PICKERING, D.S. & YE, M. (1992). Involvement of multiple suflhydryl groups in melatonin signal transduction in chick brain. Mol. Cell. Endocrinol., 85, 53-63.